HIGH

Maquet Cardiovascular Recalls Heartstring III Occluder Due to High Risk

Maquet Cardiovascular recalled 16,512 Heartstring III Proximal Seal Systems due to critical failure modes. The recall affects devices distributed globally since August 15, 2025. Users must stop using the device immediately and follow manufacturer instructions.

Quick Facts at a Glance

Recall Date
August 15, 2025
Hazard Level
HIGH
Brand
Maquet Cardiovascular
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Maquet Cardiovascular, LLC or your healthcare provider for instructions. Notification method: Letter

Product Details

The Heartstring III Proximal Seal System, Model No. HSK-3043, has 16,512 units recalled. It was distributed worldwide, including the US and multiple countries, since August 15, 2025.

The Hazard

Three failure modes have been identified: failure of the Heartstring Seal to load, failure to deploy into the aortotomy, and failure to provide adequate hemostasis. These issues pose a significant risk during medical procedures.

Reported Incidents

The recall does not specify the number of reported incidents or injuries associated with this device. However, the identified failure modes suggest a high potential for serious complications.

What to Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by Maquet Cardiovascular, LLC. Contact your healthcare provider for further guidance.

Contact Information

For more information, contact Maquet Cardiovascular, LLC or visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2588-2025.

Key Facts

  • 16,512 units recalled
  • Failure modes identified
  • Global distribution including the US
  • Immediate stop-use recommended

Get Alerts for Health & Personal Care Recalls

Get notified about recalls in categories you care about.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Model No. HSK-3043
UDI: 00607567700321
Serial No. 3000379223
3000382433
3000385929
+15 more
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE

Related Recalls

HIGH

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

SUCRALFATE
CGMP Deviations:
Read more